Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods
While patients with cystic fibrosis (CF) have had dramatic improvement in their survival rates, this has been accompanied by the emergence of more virulent pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex organisms. In addition, there has been emergence of organisms of incre...
Gespeichert in:
| Veröffentlicht in: | Letters in applied microbiology 2007-05, Vol.44 (5), p.459-466 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 466 |
|---|---|
| container_issue | 5 |
| container_start_page | 459 |
| container_title | Letters in applied microbiology |
| container_volume | 44 |
| creator | Jordan, P.W Stanley, T Donnelly, F.M Elborn, J.S McClurg, R.B Millar, B.C Goldsmith, C.E Moore, J.E |
| description | While patients with cystic fibrosis (CF) have had dramatic improvement in their survival rates, this has been accompanied by the emergence of more virulent pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex organisms. In addition, there has been emergence of organisms of increasing clinical significance such as the nontuberculous mycobacterial (NTM). Although TB infection in patients with CF is extremely uncommon, there is growing concern with regard to atypical Mycobacterium spp, in particular Mycobacterium abscessus. Many methods of decontamination of sputum, which have been adapted from TB methodologies, are ineffective; as shown by the overgrowth of P. aeruginosa, it is essential that decontamination methods are optimized to overcome this. Establishing optimal methods of isolation and determining accurate levels of prevalence is of importance as, although NTM may be isolated relatively infrequently in CF populations, their clinical status in pulmonary disease is now beginning to emerge. |
| doi_str_mv | 10.1111/j.1472-765X.2007.02130.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70411884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70411884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5020-78d9a158b803fcdce90d8ddc374d55457221119d00dadac4f33768a34157a1ce3</originalsourceid><addsrcrecordid>eNqNkc-P1SAQx4nRuM_Vf0G56K11gFKoiYeXjb-SZzzoJt4IBbrLS1tq4WW3_73UvrhH5cJM-HxnmO8ghAmUJJ-3x5JUghai5j9LCiBKoIRBef8I7f4-PEY7oHVdSMqrC_QsxiMASEKbp-iCiIoTTmCHjvu0TN7oHg-LCa02yc0-Z37snEk-jDnCk07ejSniO59usVli8gZ3vp1D9PEdPk1WJ4cza3o_bsW8mUPrQx9uFjy4dBtsfI6edLqP7sX5vkTXHz_8uPpcHL59-nK1PxSGA4VCSNtowmUrgXXGGteAldYaJirLecUFpdmCxgJYbbWpOsZELTWrCBeaGMcu0Zut7jSHXycXkxp8NK7v9ejCKSoBFSFSVv8Es7NAmOAZlBuYh4pxdp2aZj_oeVEE1LoQdVSr72r1fZUJ9Wch6j5LX557nNrB2QfheQMZeH0GdMzOdbMejY8PnKwbXguWufcbd-d7t_z3B9Rh_3WNsv7Vpu90UPpmzj2uv9M8X4YF1A1hvwEsRrFT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20001375</pqid></control><display><type>article</type><title>Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Jordan, P.W ; Stanley, T ; Donnelly, F.M ; Elborn, J.S ; McClurg, R.B ; Millar, B.C ; Goldsmith, C.E ; Moore, J.E</creator><creatorcontrib>Jordan, P.W ; Stanley, T ; Donnelly, F.M ; Elborn, J.S ; McClurg, R.B ; Millar, B.C ; Goldsmith, C.E ; Moore, J.E</creatorcontrib><description>While patients with cystic fibrosis (CF) have had dramatic improvement in their survival rates, this has been accompanied by the emergence of more virulent pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex organisms. In addition, there has been emergence of organisms of increasing clinical significance such as the nontuberculous mycobacterial (NTM). Although TB infection in patients with CF is extremely uncommon, there is growing concern with regard to atypical Mycobacterium spp, in particular Mycobacterium abscessus. Many methods of decontamination of sputum, which have been adapted from TB methodologies, are ineffective; as shown by the overgrowth of P. aeruginosa, it is essential that decontamination methods are optimized to overcome this. Establishing optimal methods of isolation and determining accurate levels of prevalence is of importance as, although NTM may be isolated relatively infrequently in CF populations, their clinical status in pulmonary disease is now beginning to emerge.</description><identifier>ISSN: 0266-8254</identifier><identifier>EISSN: 1472-765X</identifier><identifier>DOI: 10.1111/j.1472-765X.2007.02130.x</identifier><identifier>PMID: 17451510</identifier><identifier>CODEN: LAMIE7</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Bacteriological Techniques ; Biological and medical sciences ; Burkholderia cepacia ; Cystic Fibrosis - microbiology ; cystic fibrosis CF ; Fundamental and applied biological sciences. Psychology ; Humans ; Microbiology ; mycobacteria other than tubercle bacilli ; Mycobacterium ; Mycobacterium abscessus ; Mycobacterium Infections, Nontuberculous - epidemiology ; Mycobacterium Infections, Nontuberculous - microbiology ; nontuberculous mycobacteria ; Nontuberculous Mycobacteria - genetics ; Nontuberculous Mycobacteria - isolation & purification ; PCR ; Polymerase Chain Reaction ; Prevalence ; Pseudomonas aeruginosa ; tuberculosis</subject><ispartof>Letters in applied microbiology, 2007-05, Vol.44 (5), p.459-466</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5020-78d9a158b803fcdce90d8ddc374d55457221119d00dadac4f33768a34157a1ce3</citedby><cites>FETCH-LOGICAL-c5020-78d9a158b803fcdce90d8ddc374d55457221119d00dadac4f33768a34157a1ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1472-765X.2007.02130.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1472-765X.2007.02130.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18695673$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17451510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jordan, P.W</creatorcontrib><creatorcontrib>Stanley, T</creatorcontrib><creatorcontrib>Donnelly, F.M</creatorcontrib><creatorcontrib>Elborn, J.S</creatorcontrib><creatorcontrib>McClurg, R.B</creatorcontrib><creatorcontrib>Millar, B.C</creatorcontrib><creatorcontrib>Goldsmith, C.E</creatorcontrib><creatorcontrib>Moore, J.E</creatorcontrib><title>Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods</title><title>Letters in applied microbiology</title><addtitle>Lett Appl Microbiol</addtitle><description>While patients with cystic fibrosis (CF) have had dramatic improvement in their survival rates, this has been accompanied by the emergence of more virulent pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex organisms. In addition, there has been emergence of organisms of increasing clinical significance such as the nontuberculous mycobacterial (NTM). Although TB infection in patients with CF is extremely uncommon, there is growing concern with regard to atypical Mycobacterium spp, in particular Mycobacterium abscessus. Many methods of decontamination of sputum, which have been adapted from TB methodologies, are ineffective; as shown by the overgrowth of P. aeruginosa, it is essential that decontamination methods are optimized to overcome this. Establishing optimal methods of isolation and determining accurate levels of prevalence is of importance as, although NTM may be isolated relatively infrequently in CF populations, their clinical status in pulmonary disease is now beginning to emerge.</description><subject>Bacteriological Techniques</subject><subject>Biological and medical sciences</subject><subject>Burkholderia cepacia</subject><subject>Cystic Fibrosis - microbiology</subject><subject>cystic fibrosis CF</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Microbiology</subject><subject>mycobacteria other than tubercle bacilli</subject><subject>Mycobacterium</subject><subject>Mycobacterium abscessus</subject><subject>Mycobacterium Infections, Nontuberculous - epidemiology</subject><subject>Mycobacterium Infections, Nontuberculous - microbiology</subject><subject>nontuberculous mycobacteria</subject><subject>Nontuberculous Mycobacteria - genetics</subject><subject>Nontuberculous Mycobacteria - isolation & purification</subject><subject>PCR</subject><subject>Polymerase Chain Reaction</subject><subject>Prevalence</subject><subject>Pseudomonas aeruginosa</subject><subject>tuberculosis</subject><issn>0266-8254</issn><issn>1472-765X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc-P1SAQx4nRuM_Vf0G56K11gFKoiYeXjb-SZzzoJt4IBbrLS1tq4WW3_73UvrhH5cJM-HxnmO8ghAmUJJ-3x5JUghai5j9LCiBKoIRBef8I7f4-PEY7oHVdSMqrC_QsxiMASEKbp-iCiIoTTmCHjvu0TN7oHg-LCa02yc0-Z37snEk-jDnCk07ejSniO59usVli8gZ3vp1D9PEdPk1WJ4cza3o_bsW8mUPrQx9uFjy4dBtsfI6edLqP7sX5vkTXHz_8uPpcHL59-nK1PxSGA4VCSNtowmUrgXXGGteAldYaJirLecUFpdmCxgJYbbWpOsZELTWrCBeaGMcu0Zut7jSHXycXkxp8NK7v9ejCKSoBFSFSVv8Es7NAmOAZlBuYh4pxdp2aZj_oeVEE1LoQdVSr72r1fZUJ9Wch6j5LX557nNrB2QfheQMZeH0GdMzOdbMejY8PnKwbXguWufcbd-d7t_z3B9Rh_3WNsv7Vpu90UPpmzj2uv9M8X4YF1A1hvwEsRrFT</recordid><startdate>200705</startdate><enddate>200705</enddate><creator>Jordan, P.W</creator><creator>Stanley, T</creator><creator>Donnelly, F.M</creator><creator>Elborn, J.S</creator><creator>McClurg, R.B</creator><creator>Millar, B.C</creator><creator>Goldsmith, C.E</creator><creator>Moore, J.E</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><general>Blackwell Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200705</creationdate><title>Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods</title><author>Jordan, P.W ; Stanley, T ; Donnelly, F.M ; Elborn, J.S ; McClurg, R.B ; Millar, B.C ; Goldsmith, C.E ; Moore, J.E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5020-78d9a158b803fcdce90d8ddc374d55457221119d00dadac4f33768a34157a1ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Bacteriological Techniques</topic><topic>Biological and medical sciences</topic><topic>Burkholderia cepacia</topic><topic>Cystic Fibrosis - microbiology</topic><topic>cystic fibrosis CF</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Microbiology</topic><topic>mycobacteria other than tubercle bacilli</topic><topic>Mycobacterium</topic><topic>Mycobacterium abscessus</topic><topic>Mycobacterium Infections, Nontuberculous - epidemiology</topic><topic>Mycobacterium Infections, Nontuberculous - microbiology</topic><topic>nontuberculous mycobacteria</topic><topic>Nontuberculous Mycobacteria - genetics</topic><topic>Nontuberculous Mycobacteria - isolation & purification</topic><topic>PCR</topic><topic>Polymerase Chain Reaction</topic><topic>Prevalence</topic><topic>Pseudomonas aeruginosa</topic><topic>tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jordan, P.W</creatorcontrib><creatorcontrib>Stanley, T</creatorcontrib><creatorcontrib>Donnelly, F.M</creatorcontrib><creatorcontrib>Elborn, J.S</creatorcontrib><creatorcontrib>McClurg, R.B</creatorcontrib><creatorcontrib>Millar, B.C</creatorcontrib><creatorcontrib>Goldsmith, C.E</creatorcontrib><creatorcontrib>Moore, J.E</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Letters in applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jordan, P.W</au><au>Stanley, T</au><au>Donnelly, F.M</au><au>Elborn, J.S</au><au>McClurg, R.B</au><au>Millar, B.C</au><au>Goldsmith, C.E</au><au>Moore, J.E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods</atitle><jtitle>Letters in applied microbiology</jtitle><addtitle>Lett Appl Microbiol</addtitle><date>2007-05</date><risdate>2007</risdate><volume>44</volume><issue>5</issue><spage>459</spage><epage>466</epage><pages>459-466</pages><issn>0266-8254</issn><eissn>1472-765X</eissn><coden>LAMIE7</coden><abstract>While patients with cystic fibrosis (CF) have had dramatic improvement in their survival rates, this has been accompanied by the emergence of more virulent pathogens such as Pseudomonas aeruginosa and Burkholderia cepacia complex organisms. In addition, there has been emergence of organisms of increasing clinical significance such as the nontuberculous mycobacterial (NTM). Although TB infection in patients with CF is extremely uncommon, there is growing concern with regard to atypical Mycobacterium spp, in particular Mycobacterium abscessus. Many methods of decontamination of sputum, which have been adapted from TB methodologies, are ineffective; as shown by the overgrowth of P. aeruginosa, it is essential that decontamination methods are optimized to overcome this. Establishing optimal methods of isolation and determining accurate levels of prevalence is of importance as, although NTM may be isolated relatively infrequently in CF populations, their clinical status in pulmonary disease is now beginning to emerge.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>17451510</pmid><doi>10.1111/j.1472-765X.2007.02130.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0266-8254 |
| ispartof | Letters in applied microbiology, 2007-05, Vol.44 (5), p.459-466 |
| issn | 0266-8254 1472-765X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70411884 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Bacteriological Techniques Biological and medical sciences Burkholderia cepacia Cystic Fibrosis - microbiology cystic fibrosis CF Fundamental and applied biological sciences. Psychology Humans Microbiology mycobacteria other than tubercle bacilli Mycobacterium Mycobacterium abscessus Mycobacterium Infections, Nontuberculous - epidemiology Mycobacterium Infections, Nontuberculous - microbiology nontuberculous mycobacteria Nontuberculous Mycobacteria - genetics Nontuberculous Mycobacteria - isolation & purification PCR Polymerase Chain Reaction Prevalence Pseudomonas aeruginosa tuberculosis |
| title | Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A25%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atypical%20mycobacterial%20infection%20in%20patients%20with%20cystic%20fibrosis:%20update%20on%20clinical%20microbiology%20methods&rft.jtitle=Letters%20in%20applied%20microbiology&rft.au=Jordan,%20P.W&rft.date=2007-05&rft.volume=44&rft.issue=5&rft.spage=459&rft.epage=466&rft.pages=459-466&rft.issn=0266-8254&rft.eissn=1472-765X&rft.coden=LAMIE7&rft_id=info:doi/10.1111/j.1472-765X.2007.02130.x&rft_dat=%3Cproquest_cross%3E70411884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20001375&rft_id=info:pmid/17451510&rfr_iscdi=true |